(Q37156581)

18 August 2017

1 reference

title

Treatment of pediatric hodgkin lymphoma (English)

1 reference

18 August 2017

Michael R Olson

1

1 reference

18 August 2017

Sarah S Donaldson

series ordinal

2

1 reference

18 August 2017

publication date

1 February 2008

1 reference

Current Treatment Options in Oncology

18 August 2017

published in

1 reference

18 August 2017

volume

9

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

81-94

1 reference

Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11864-008-0058-0

Radiation induced height impairment in pediatric Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-008-0058-0

Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-008-0058-0

A pilot study of EVAP/ABV chemotherapy in 25 newly diagnosed children with Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-008-0058-0

Increased mortality after successful treatment for Hodgkin's disease.

21 January 2018

1 reference

12 December 2020

Second cancers following pediatric Hodgkin's disease.

1 reference

12 December 2020

Rationale for the use of alternating non-cross-resistant chemotherapy.

1 reference

12 December 2020

Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group

1 reference

12 December 2020

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

1 reference

12 December 2020

Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook

1 reference

12 December 2020

Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: an interim report at 5 years of the German GPOH-HD 95 trial

1 reference

12 December 2020

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease

1 reference

12 December 2020

Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma

1 reference

12 December 2020

Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.

1 reference

12 December 2020

MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial

1 reference

12 December 2020

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

12 December 2020

Treatment of childhood Hodgkin's disease without radiotherapy

1 reference

12 December 2020

Second malignancy after treatment of pediatric Hodgkin disease.

1 reference

12 December 2020

VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial

1 reference

12 December 2020

Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology

1 reference

12 December 2020

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy

1 reference

12 December 2020

Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease

1 reference

12 December 2020

Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study

1 reference

12 December 2020

Lymphocyte predominant Hodgkin disease: clinico-pathologic features and results of treatment--the Pediatric Oncology Group experience

1 reference

12 December 2020

Treatment of pediatric Hodgkin's lymphoma.

1 reference

12 December 2020

Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: a report from the Children's Cancer Study Group

1 reference

12 December 2020

High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin's disease: results and prognostic indices

1 reference

12 December 2020

Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.

1 reference

12 December 2020

Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation

1 reference

12 December 2020

Second cancers after pediatric Hodgkin's disease

1 reference

12 December 2020

Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease

1 reference

12 December 2020

Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease

1 reference

12 December 2020

Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease

1 reference

12 December 2020

Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy

1 reference

12 December 2020

POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group

1 reference

12 December 2020

Cardiac disease following treatment of Hodgkin's disease in children and adolescents

1 reference

12 December 2020

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

1 reference

12 December 2020

Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study

1 reference

12 December 2020

Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a Study of the French Society of Pediatric Oncology

1 reference

12 December 2020

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial

1 reference

12 December 2020

Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90

1 reference

12 December 2020

10.1007/S11864-008-0058-0

Identifiers

DOI

1 reference

18 August 2017

1 reference